Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

34 results about "Sequence dependent" patented technology

A method and a system for executing a scheduled production process

A method and a system for executing a scheduled production process having an execution duration within a production schedule executed and controlled by a manufacturing execution system are disclosed, comprising the steps of: a) defining within the production process a resource required for the execution of the production process (STEP1) ; b) defining for the resource a sequence-dependent setup sub-process having a setup duration, a productive sub-process having a production duration and a sequence-dependent teardown sub-process having a teardown duration (STEP2); c) scheduling the production process for its execution with a start-time on a production schedule wherein the scheduled execution duration is the sum of the setup duration, the production duration and the teardown duration (STEP3); d) at a predetermined period prior to or at the start-time of the production process, confirming the production process for dispatching and subsequent executing (STEP4); e) in response to the confirmation of the production process for dispatching, creating individual production processes for the sequence-dependent setup sub-process, the production sub-process and the teardown sub-process, whereby the created individual production processes are linked together by precedence constraints defining a sequence of the created individual production processes (STEP5) ; f) re-scheduling the production schedule through replacing the production process by the created individual production processes (STEP6); and g) executing the re-scheduled production schedule by dispatching the created individual production in the scheduled sequence (STEP7).
Owner:SIEMENS AG

5' protection dependent amplification

The present invention relates to methods for generating a labelled nucleic acid from an RNA comprising a 5′ protecting group, said method comprises the steps of obtaining a mixture of template strands of nucleic acids, said mixture comprising said RNA and further potentially other nucleic acids without a 5′ protecting group, annealing at least one oligonucleotide primer to the template strand of said RNA and potentially other nucleic acids, and template sequence dependent extending said primer, thereby obtaining a complementary nucleic acid strand annealed to its template strand, or providing the RNA in duplex with a complementary nucleic acid strand annealed to its template strand, andoptionally modifying the extension product of said nucleic acids without 5′ protecting group either on the 5′ end of the template strand or on the 3′ end of the complementary strand, or both, and labelling a complementary nucleic acid of a double stranded nucleic acid not modified, wherein therefore the labelled nucleic acid did have a 5′ protecting group on the RNA template strand, said 5′ protecting group being optionally removed after modification, and / or labelling a complementary nucleic acid of a double strand dependent on the presence of the 5′ protecting group on the complementary nucleic acids template RNA strand by double strand dependent ligation, thereby specifically generating a labelled nucleic acid complementary to an RNA at least originally comprising a 5′ protecting group.
Owner:LEXOGEN GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products